Shyanne Ali has over 20 years of pharmaceutical drug development experience in the areas of Global Clinical Operations, Global Clinical Development, and Quality Assurance. Over the course of her career, Shyanne has led Global R&D Quality organization at Boehringer Ingelheim, Intercept Pharma and tech start-up, TrialSpark. Prior to her leadership roles in Quality Assurance, she held leadership roles in global clinical operations functions at Abbott Laboratories, Novartis Oncology and Novartis Vaccines.